Uday Patel

Uday Patel is the Head of Regulatory Affairs/Quality at Allievex. Uday has over 25 years of experience in the pharmaceutical and biotechnology industry, including roles in analytical, quality and regulatory affairs. Uday has been a partner and key member of senior management and scientific project teams in successful start-ups to clinical stage organizations. Uday’s background includes global experience within regulatory and quality with broad experience across multiple disciplines of product development. Uday has a wide range of experience working on early to late stage clinical programs spanning various indications including infectious diseases & vaccines, metabolic disorders, respiratory and inflammatory diseases and women’s health. Most recently, Uday served as Vice President of Regulatory Affairs and Quality at Airway Therapeutics leading the company’s novel first-in-class biologic for treatment of various respiratory and inflammatory diseases. Uday also held positions at Femasys, Vaxart, Aviragen Therapeutics, GSK, Inhibitex, Peptimmune and Altus Pharmaceuticals.

Uday has a Bachelor’s degree in Biochemistry from Suffolk University and a Master of Liberal Arts (ALM) degree in Biology from Harvard University. Uday has received regulatory affairs certification (RAC) for US and EU from the regulatory affairs professionals society (RAPS).